SpiceJet Receives BSE Nod For Fund Infusion of Rs 2242 Crore

Spicejet's shares saw a flat rise of 0.73% on Monday after rising to an intraday high of Rs 65.79 from their opening price of Rs 65.31 on the BSE. SpiceJet Ltd.'s announcement that the Bombay Stock Exchange (BSE) has granted in-principle permission for the issue of equity shares and warrants convertible into equity shares on a preferential basis would likely cause the stock to gain attention. This decision opens the door for a fresh Rs 2242 crore financial inflow and represents a major turning point for the company.

SpiceJet is able to go forward with the cash infusion process thanks to the BSE's in-principle clearance, which gives the airline the financial boost it needs for its expansion plans. The decision follows the successful 39th Annual General Meeting (AGM) of SpiceJet on January 10, when the proposal for a Rs 2242 crore fund infusion was unanimously approved by the Board members.

Spicejet said a significant portion of the fund infusion will be utilized to fuel the airline's growth, expand its network, bring grounded planes back into operation and position itself as a more resilient and competitive player in the aviation industry.

Ajay Singh, Chairman and Managing Director of SpiceJet, said, "The in-principle approval from BSE for the fund infusion is a crucial step for SpiceJet as we embark on a journey to enhance our capabilities and strengthen our position in the Indian aviation sector. We believe the fund infusion will open new avenues for SpiceJet, enabling us to capitalise on potential opportunities and contribute to the growth of the aviation sector in India."

In December, SpiceJet Ltd.'s board decided to raise more than Rs 2,250 crore by preferential issue of shares and warrants. The airline stated in the notice to the AGM that it intends to raise the funds in two tranches i.e. Rs 650 crore by July 2025 and Rs 1,591.5 crore by June 2024.